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ABSTRACT
Objectives This study provides an overview of the 
influence of occupational risk factors on the global 
burden of disease as estimated by the occupational 
component of the global Burden of Disease (gBD) 2016 
study.
Methods The gBD 2016 study estimated the burden in 
terms of deaths and disability- adjusted life years (DalYs) 
arising from the effects of occupational risk factors 
(carcinogens; asthmagens; particulate matter, gases 
and fumes (PMgF); secondhand smoke (shs); noise; 
ergonomic risk factors for low back pain; risk factors for 
injury). a population attributable fraction (PaF) approach 
was used for most risk factors.
Results in 2016, globally, an estimated 1.53 (95% 
uncertainty interval 1.39–1.68) million deaths and 
76.1 (66.3–86.3) million DalYs were attributable to 
the included occupational risk factors, accounting for 
2.8% of deaths and 3.2% of DalYs from all causes. 
Most deaths were attributable to PMgF, carcinogens 
(particularly asbestos), injury risk factors and shs. 
Most DalYs were attributable to injury risk factors and 
ergonomic exposures. Men and persons 55 years or older 
were most affected. PaFs ranged from 26.8% for low 
back pain from ergonomic risk factors and 19.6% for 
hearing loss from noise to 3.4% for carcinogens. DalYs 
per capita were highest in Oceania, southeast asia 
and central sub- saharan africa. On a per capita basis, 
between 1990 and 2016 there was an overall decrease 
of about 31% in deaths and 25% in DalYs.
Conclusions Occupational exposures continue to cause 
an important health burden worldwide, justifying the 
need for ongoing prevention and control initiatives.
InTROduCTIOn
A safe and healthy work environment is a funda-
mental right of all workers. Burden of disease 
studies are an important source of information on 
the level of ill health in communities and on the 
risk factors that contribute to this ill health.1 The 
results provide guidance to policymakers in terms 
of where resources might best be used and can 
provide insight into the effectiveness or otherwise 
of past interventions. The results can also be used 
to underpin studies of the cost of injury and illness.
Estimates of the worldwide burden of occu-
pational disorders (diseases and injuries) suggest 
occupational risk factors make an important 
contribution to the burden of ill health,2 3 and there 
are large variations in and between countries in 
the estimated incidence of occupational disorders.4 
Global estimates of economic costs arising from 
occupational disorders vary between 1.8% and 
6.0% of gross domestic product.5 In principle, most 
occupational disorders can be prevented by means 
of control measures targeted at relevant risk factors.
Prior Global Burden of Disease (GBD) studies 
have estimated the global burden for 19906 and 
2010,7 with the 2010 GBD study updated several 
times.8–11 Occupational risk factors formed one 
group of risk factors that was included in the GBD- 
related Comparative Risk Assessment (CRA) study, 
focused on 2000.3 The occupational risk factors 
included in GBD 2016 were carcinogens; asthma-
gens; particulate matter, gases and fumes (PMGF); 
Key messages
What is already known about this subject?
 ► Occupational risk factors have previously been 
identified as being an important cause of 
disease and injury burden.
 ► However, there has been no comprehensive 
update since 2000 using burden of disease 
methodology.
What are the new findings?
 ► Carcinogens; particulate matter, gases 
and fumes; and risk factors for injury were 
responsible for the greatest burden in terms of 
deaths.
 ► Ergonomic exposures associated with low 
back pain, injury risk factors and noise were 
responsible for the greatest overall burden 
(as measured by disability- adjusted life years 
(DALYs)).
 ► Men had much higher rates of deaths and 
DALYs than women.
 ► There was an overall reduction in rates of 
deaths and DALYS between 1990 and 2016.
How might this impact on policy or clinical 
practice in the foreseeable future?
 ► Occupational exposures are largely controllable 
and should be a focus for prevention activity in 
all regions.
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secondhand smoke (SHS); noise; ergonomic risk factors for 
low back pain; and risk factors for occupational injury. The 
study attempted to overcome some of the shortcomings asso-
ciated with the earlier analyses, including some additional risk 
factors and associated outcomes and using modified method-
ology. The main GBD risk factors paper provides some high- 
level information on occupational risk factors.10 This paper and 
two companion papers12 13 describe in more detail the methods, 
results and strengths and limitations of the occupational risk 
factor analysis from GBD 2016.
MeTHOdS
General approach
The GBD 2016 study evaluated the burden of disease (deaths or 
disability- adjusted life years (DALYs)) attributable to past expo-
sure to various risk factors. Attributable burden was estimated by 
comparing observed health outcomes to those that would have 
been observed if a counterfactual level of exposure (the theo-
retical minimum risk exposure level (TMREL)) had occurred. 
‘Occupational exposure’ was defined as being experienced in 
the course of an activity undertaken for pay, profit or kind. It 
excluded home duties. The burden of occupational disease for 
each risk factor–outcome pair was estimated using the popula-
tion attributable fraction (PAF), that is, the proportion of deaths 
or DALYs that would not have occurred if exposure was at the 
TMREL; this was then used to estimate attributable numbers 
of deaths or DALYs. The PAF requires information on the rela-
tive risk of the disease due to the exposure of interest and the 
proportion of the target population exposed. The risk estimates 
(relative risks or ORs) were primarily obtained from published 
meta- analyses or pooled studies or, where these did not exist, 
key single studies were used. Where single studies were used, 
the chosen study was the best quality study (as judged by the 
Occupational Risk Factors Expert Working Group) with expo-
sure circumstances that were assessed as most closely matching 
those assumed in the GBD study. For carcinogens, PMGF, noise 
and ergonomic risk factors related to low back pain, most rela-
tive risks used in the analysis compared occupationally exposed 
to non- occupationally exposed, assuming similar exposure dura-
tions and intensities across countries and regions. The same 
relative risks were assumed to apply for calculation of burden 
of deaths and of DALYs. High- income countries were defined 
as countries in the Australasia, high- income North America, 
Western Europe, and high- income Asia Pacific regions, and low 
and middle- income (LMI) countries as all other countries. Risk 
factor–outcome pairs were selected where there was judged to 
be reliable data on both the exposure and the associated risk 
measures, the level of evidence supporting a causal association 
was sufficiently strong and the resulting burden was likely to be 
more than trivial.
PAFs were estimated for each age- sex- country group using the 
equation based on Levin14:
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where P(x) is the proportion of persons exposed at level x 
in the relevant population and RR(x) is the relative risk corre-
sponding to exposure level x.
Relative risks based on high exposed and low exposed, relative 
to those with background exposure, were used in lieu of more 
sophisticated measures of risk because the necessary quantita-
tive information on exposure was not available. The age- sex- 
country- specific PAFs were multiplied by the total number of 
deaths in 2016 in the relevant age- sex- country group to produce 
the number of deaths in the age- sex- country- specific group for 
the relevant risk factor–outcome pair. These deaths in specific 
groups were summed to produce the total number of deaths 
from a given outcome resulting from the relevant exposure. This 
total was divided by the total number of deaths from all causes 
for a given outcome to produce an all- age PAF for the relevant 
risk factor–outcome pair. This was done separately by sex and 
for both sexes combined, and separately by country and region 
and for all regions combined. PAFs based on DALYs were calcu-
lated in the same way. A combined PAF for an outcome with 
multiple contributing exposures was calculated using the stan-
dard product- sum approach.14 15
 PAFcombined = 1−Πk(1− PAFk) (for k exposures). 
A different approach was used for occupational injury risk 
factors and resultant injuries, with information on the number of 
injuries coming directly from International Labour Organization 
(ILO) information, and for pneumoconiotic dusts and pneumo-
coniosis, with information estimated as part of the overall GBD 
estimates of prevalence and deaths for each included cause.
Results were calculated for all years from 1990 to 2016, 
inclusive; the 2016 findings are the focus of this paper. Only 
attributable burden in persons 15 years and above is included. 
Region- specific, sociodemographic index (SDI)- specific and 
global results are reported here. The SDI is a composite indicator 
of development status based on total fertility rate, mean educa-
tion for those aged 15 years and older and lag distributed income 
per capita.10 The PAFs presented were based on DALYs unless 
otherwise indicated and were based on all ages. Per capita rates 
(age and sex standardised) were based only on persons aged 15 
years and above, unless otherwise stated. The number, rate and 
proportion of the various outcomes each provide insight into 
different aspects of the burden, with the number reflecting abso-
lute burden and the rates more useful when comparing burden 
between countries or between different time periods.
employment data
For carcinogens, PMGF, SHS and noise, the proportion of ever- 
exposed persons was based on the estimated proportion of each 
national population in the workforce, the proportion of the 
workforce in specific industries and the proportion of workers 
estimated to be exposed in that industry. For asthmagens and 
ergonomic risk factors, the proportion currently exposed was 
based on the proportion of the workforce in specific occupations 
rather than industries. Information on industry (nine categories), 
occupation (eight categories) and the proportion of the popu-
lation which was working (the Economically Active Population 
(EAP)) for each country was obtained from the ILO Labour 
Force.16 Employment data from the year being examined were 
used for all risk factors except carcinogens, for which informa-
tion on employment in previous years was also included to take 
account of latency and persistent risk. Available occupation and 
industry information was available by sex but not age. The EAP 
was available separately for males and females and for each GBD 
age group. Where the ILO data did not provide sufficient infor-
mation for a country, information was obtained from subna-
tional data sources, supplemented where necessary by modelling 
on a preselected list of covariates (such as log lagged distributed 
income, education per capita and urbanicity). In particular, for 
China, subnational data were extracted at the province level 
using census and national population sample surveys. For India, 
there were no national labour force data, resulting in the esti-
mates being based on models driven by country- level covariates.
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Table 1 Global occupation- attributable deaths, DALYs and PAFs by risk factor and sex, 2016 (number, per cent and proportion (95% uncertainty 
interval))
deaths dALYs PAFs*
Males† Females Total %‡ Males Females Total %§ Males Females Total
Carcinogens 274 175 74 566 348 741 22.8 5 560 418 1 639 432 7 199 850 9.5 4.5 1.8 3.4
(215 339–333 
928)
(60 870–89 
775)
(282 253–414 
071)
(4 375 804–6 
734 491)
(1 312 494–2 
017 294)
(5 813 091–8 
641 244)
(3.6–5.5) (1.5–2.2) (2.7–4.0)
PMGF+SHS¶ 343 122 116 958 460 080 30.0 7 969 986 2 717 967 10 687 953 14.0 21.1 10.6 16.9
(270 900–422 
000)
(87 100–153 
300)
(381 500–551 
300)
(6 518 000–9 
469 200)
(2 143 400–3 
328 600)
(9 019 900–12 
517 000)
(17.4–24.8) (8.5–12.9) (14.3–19.7)
Injury risk factors 301 043 31 508 332 550 21.7 18 799 904 2 632 725 21 432 629 28.2 10.6 3.4 8.4
(289 315–313 
036)
(29 829–33 
125)
(320 989–344 
650)
(17 168 108–20 
722 961)
(2 241 086–3 
117 772)
(19 461 136–
23 891 462)
(10.2–11.1) (3.1–3.7) (8.1–8.7)
Asthmagens 26 103 11 471 37 574 2.5 1 468 347 871 133 2 339 480 3.1 12.9 7.1 9.9
(17 900–35 
300)
(8700–15 
200)
(28 400–47 
900)
(1 141 200–1 
874 300)
(666 100–1 109 
600)
(1 860 900–2 
923 300)
(11.5–14.3) (6.3–8.0) (9.0–10.7)
Pneumoconioses 18 997 2491 21 488 1.4 518 917 58 060 576 977 0.8 1.0 1.0 1.0
(15 500–22 
700)
(2100–3200) (17 900–25 
400)
(439 900–611 
300)
(49 400–70 
700)
(493 600–673 
500)
SHS (excluding cancer and 
COPD**)
222 933 109 065 331 998 21.7 7 622 593 3 685 843 11 308 436 14.9 – – –
(147 461–304 
921)
(68 890–152 
887)
(216 952–455 
510)
(4 850 498–10 
571 425)
(2 202 327–5 
270 793)
(7 041 695–15 
788 968)
Ergonomic risk factors 0 0 0 – 8 463 913 7 016 018 15 479 932 20.3 32.5 22.2 26.8
(5 874 618–11 
346 133)
(4 844 189–9 
423 787)
(10 733 369–
20 772 446)
(30.4–34.5) (20.5–24.1) (25.0–28.8)
Noise 0 0 0 – 4 711 557 2 396 720 7 108 277 9.3 25.1 13.7 19.6
(3 294 182–6 
488 167)
(1 680 298–3 
296 175)
(4 978 557–9 
802 692)
(23.2–26.9) (12.8–14.8) (18.2–21.1)
Total 1 186 372 346 058 1 532 431 100.0 55 115 652 21 017 906 76 133 558 100.0 4.2 1.9 3.2
(1 066 502–1 
311 010)
(299 889–
398 048)
(1 387 905–1 
684 933)
(48 614 027–61 
653 859)
(17 388 026–24 
953 299)
(66 277 451–
86 347 358)
(4.0–4.5) (1.7–2.1) (3.0–3.4)
*PAFs (%) based on DALYs.
†The numbers in parentheses are the 95% uncertainty interval.
‡Percentage of deaths due to occupational risk factors that were due to this risk factor.
§Percentage of DALYs due to occupational risk factors that were due to this risk factor.
¶Particulate matter, gases and fumes (PMGF) and secondhand smoke (SHS) causing COPD.
**Diseases caused by SHS, excluding cancer and COPD.
COPD, chronic obstructive pulmonary disease; DALY, disability- adjusted life year; PAF, population attributable fraction.
estimation of uncertainty
Ninety- five per cent uncertainty intervals (95% UI) were used 
rather than CIs. These attempt to take into account uncertainty 
from all input data components (exposure, relative risk, TMREL 
and burden), rather than just being based on random sampling, 
and were calculated as the 2.5th and 97.5th percentiles of 1000 
draws taken from an assumed distribution of all relevant vari-
ables.10 Uncertainty intervals are primarily presented in detail in 
the tables to assist with the flow of the text.
More details on the methods used are provided in the online 
supplementary material, in companion papers on specific risk 
factors12 13 and on the GBD website, including those for specific 
countries, using the GBD Compare data visualisation.17
ReSuLTS
In 2016, there were an estimated 1.53 (95% UI 1.39–
1.68) million deaths attributable to exposure to work- related 
risk factors included in this study. This represented 2.7% of 
all deaths in 2016 (3.1% of those aged 15 years or more). The 
risk factors resulting in the most deaths were PMGF and SHS 
resulting in chronic obstructive pulmonary disease (COPD) 
(30%), with carcinogens (23%), injury risk factors (22%) and 
SHS resulting in other diseases (22%) causing a similar number 
of deaths (table 1). The majority (77%) of the deaths occurred 
in males.
In terms of DALYs, there were 76.1 (95% UI 66.3–86.3) million 
DALYs globally, 3.2% of total DALYs in 2016 (4.2% of those 
aged 15 years or more), with 72% occurring in males. The risk 
factors resulting in the greatest overall burden, as measured 
in DALYs, were injury risk factors (28%) and ergonomic risk 
factors (20%) (table 1).
The PAFs (based on DALYs) ranged from 3.4% for carcino-
gens to 19.6% for noise and 26.8% for ergonomic risk factors 
(table 1). The PAFs based on deaths ranged from 3.9% for 
carcinogens to 15.7% for PMGF and SHS resulting in COPD.
Age
Seventy- six per cent of deaths but only 39% of DALYs occurred 
in persons aged 55 years and older. The mortality rate increased 
with increasing age, more markedly in men than women. For 
DALYs, from age 35 years the rate increased to age 65–74 years 
but dropped in older persons (figure 1).
Regions
Carcinogens were responsible for the largest number of deaths 
in all high- income regions (primarily attributable to asbestos- 
related cancers, which comprised about 80% of all deaths due 
to carcinogens in these regions) but only one of the LMI regions 
(Central Europe). Injury risk factors caused the highest number 
of deaths in half the other regions. SHS and PMGF also were 
responsible for a considerable number of deaths (online supple-
mentary table S1). This pattern was similar in terms of DALYs, 
with additional important contribution from ergonomic risk 
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Figure 1 Occupation- attributable deaths and DalYs, by age and sex, 2016 (per 100 000 persons). DalY, disability- adjusted life year.
factors resulting in low back pain. Carcinogens were responsible 
for the highest burden in three of the four high- income regions; 
in most other regions, injury risk factors were responsible for the 
highest or second- highest burden proportions (figure 2, online 
supplementary table S2).
The highest number of deaths and DALYs was in the regions 
with the largest populations—East Asia and South Asia. The 
highest rates of deaths were in Oceania, East Asia and South 
Asia, but rates were also high in most high- income regions, 
whereas for DALYs the highest rates were in Oceania, Southeast 
Asia and Central sub- Saharan Africa, and high- income regions 
had the lowest rates. Rates of both were highest in low and low- 
middle SDI regions (figure 3).
Changes over time
Between 1990 and 2016 there was a 16% increase in deaths 
and a 22% increase in DALYs attributable to occupational risk 
factors. However, rates provide more useful information as they 
take into account population changes. On a per capita basis, 
there was an overall decrease of about 31% for deaths and 25% 
for DALYs, and a considerable percentage decrease in burden, 
whether measured in deaths or DALYs, for most individual risk 
factors. The exceptions were SHS- related disease (excluding 
cancer and COPD), ergonomic risk factors and noise, all of 
which changed little (table 2).
The rates of deaths and DALYs fell across all regions, but the 
proportionate fall varied considerably between regions, ranging 
from 15% (Southern Latin America) to 54% (East Asia) for 
deaths and from 6% (Southern Latin America and Western sub- 
Saharan Africa) to 43% (East Asia) for DALYs (online supple-
mentary table S3).
dISCuSSIOn
This analysis shows that occupational risk factors are responsible 
for a sizeable proportion of all ill health and injury across the 
world as measured by deaths (2.8%) and DALYs (3.2%). This is 
notwithstanding that it was not possible to include all potentially 
important occupational risk factors (considered below). Injury 
risk factors and ergonomic risk factors resulting in low back pain 
were responsible for the biggest overall burden, and PMGF and 
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Figure 2 Occupation attributable disability- adjusted life years (DalYs) per capita by region, 2016, per cent. cOPD, chronic obstructive pulmonary disease; 
PMgF, particulate matter, gases and fumes; sDi, sociodemographic index; shs, secondhand smoke.
SHS resulting in COPD were the largest single category in terms 
of deaths related to occupational exposures. The total burden 
has risen considerably since 1990. However, when taking into 
account increases in the population, the per capita burden for 
all risk factors has actually decreased, though to varying extents. 
Since the exposure assessments are primarily based on occu-
pation or industry, most of the changes reflect changes in the 
occupational and industrial distribution of workers as opposed 
to changes in exposure.
Other estimates of global occupational burden
The overall methods of the CRA 2000 study3 and the current 
study were similar, but there were some important differences in 
terms of the exposures and outcomes included, the risk measures 
(due to updates in the literature), the population numbers, the 
approach to estimating the population at risk (which was more 
detailed in the current study than was possible for the CRA 2000 
study) and the approach to estimating the prevalence of expo-
sure to asbestos. The CRA study estimated there were 820 000 
deaths in 2000 from exposure to occupational risk factors, 
compared with the estimates in the current study—1.42 million 
deaths in 2000 and 1.53 million deaths in 2016. The differ-
ences arise mainly from the current study estimating twice as 
many deaths from cancer and 50% more deaths from COPD, 
and including SHS- associated outcomes apart from cancer and 
COPD (such as cardiovascular disease). Other estimates of 
global burden estimate a considerably larger burden of deaths, 
primarily attributable to a much broader inclusion of exposures 
and outcomes arising from less restrictive criteria for the strength 
of the required evidence and not including the equivalent of a 
counterfactual.5
Implications and uses of the data
There are several clear implications of the results arising from 
this study. Most importantly, exposures at work remain an 
important risk factor for a number of outcomes in all regions 
of the world. The burden arising from carcinogens and noise, 
and to a lesser extent PMGF and SHS causing COPD, primarily 
reflects the effects of occupational exposures in past decades, 
but many of these exposures still occur. Published information 
does suggest average levels for many exposures have decreased 
over time, particularly in high- income countries, but much of 
the data are for inhalational exposures and many instances of 
high exposure remain.18–21 With the transition of much heavy 
industry and manufacturing from high- income to LMI countries, 
the adverse experience of high- income countries is likely to be 
reflected in the future burden for LMI countries unless signifi-
cant steps are taken to eliminate the problem exposures where 
possible, and otherwise to control them effectively.22 Asbestos 
is a striking example, where current exposures continue in LMI 
countries, with a clearly predictable and devastating future 
burden if current and future exposures are not prevented. In 
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Figure 3 Occupation- attributable DalYs by region, 2016 (per 100 000 persons). DalY, disability- adjusted life year; sDi, sociodemographic index.
addition, concerns regarding new exposures (eg, nanoparticles) 
and new exposure situations (eg, silica exposure from artificial 
stone bench tops) suggest that just controlling the exposures that 
are included in the current analysis will not eliminate all future 
ill health arising from occupational exposures.
This study does not provide information on the cost or techno-
logical feasibility of eliminating or reducing exposures, or on the 
uptake of known effective prevention strategies. Thus, it cannot 
fully inform priorities for resource allocation to decrease the 
burden from the risk factors considered in this study, assuming 
that deaths or DALYs preventable per unit expenditure would 
be taken into account. Nevertheless, the elimination of asbestos 
exposure is already well recognised as a priority,23 and the results 
presented here serve to further emphasise the importance of this. 
Excessive noise, many ergonomic exposures, injury risk factors 
and SHS exposures are clearly eminently preventable in many 
settings, and better control of them would be expected to lead 
to significant reduction in the burden of disease arising from 
occupational exposures affecting the global population. Most of 
the assessed exposures and the resulting burden are entirely or 
largely avoidable and in many instances the individual worker 
has little influence over the level of exposure experienced, 
emphasising the need for and importance of controls at the 
organisational and societal level.
Methodological considerations and limitations
In any study of the type presented here there are uncertainties 
arising from shortcomings in the data that necessitate significant 
assumptions. Those made in this study were based on available 
data and, where necessary, expert opinion of GBD authors. The 
main uncertainties in the data, and the potential implications of 
these, are briefly considered below. Where they could be quanti-
fied to some extent, they were incorporated into the uncertainty 
intervals. More detailed consideration of some of these issues is 
provided in the companion papers.12 13
Workforce data
The workforce data came from the ILO database, supplemented, 
where necessary, by information from other sources such as 
regional surveys. For South Asia (which is predominantly India) 
and East Asia (which is predominantly China)—the two largest 
regions—there were limited available data. Some countries did 
have available data but only for broad industry and occupation 
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Table 2 Change in global occupation- attributable deaths and DALYs between 1990 and 2016 (per 100 000 persons) (number (95% uncertainty 
interval) and per cent)
Risk factor
deaths per 100 000 persons* dALYs per 100 000 persons*
1990† 2016 % change 1990 2016 % change
Carcinogens 15.0 13.5 −9.8 320 272 −14.8
  (12.1–18.1) (11.0–16.0)   (256–386) (220–326)   
PMGF+SHS‡ 31.0 18.2 −41.3 653 410 −37.1
  (25.8–36.5) (15.0–21.9)   (545–768) (346–482)   
Injury risk factors 22.6 12.0 −46.8 1381 779 −43.6
  22.1–23.2) (11.8–12.3)   (1285–1503) (708–862)   
Asthmagens 2.2 1.4 −36.0 108 85 −21.4
  (1.5–3.0) (1.0–1.8)   (82–136) (67–106)   
Pneumoconioses 1.4 0.8 −41.3 36 22 −39.7
  (1.1–2.1) (0.7–1.0)   (28–53) (19–26)   
  SHS (excluding cancer and COPD)§ 12.8 12.6 −1.4 391 417 6.6
  (8.7–17.2) (8.2–17.3)   (259–532) (260–582)   
Ergonomic risk factors       574 556 −3.2
        (396–775) (386–746)   
Noise       246 260 5.4
        (172–338) (182–358)   
Total 84.9 58.6 −31.1 3709 2800 −24.5
  (71.3–100.1) (47.7–70.2)   (3023–4490) (2188–3488)   
*These rates are age and sex standardised.
†The numbers in parentheses are the 95% uncertainty interval.
‡Particulate matter, gases and fumes (PMGF) and secondhand smoke (SHS) causing chronic obstructive pulmonary disease (COPD).
§Diseases caused by SHS, excluding cancer and COPD.
DALY, disability- adjusted life year.
categories. Gaps were filled through modelling of the available 
data for the country and extrapolation from countries in the 
region for which data were available. The extent and effect of 
error arising from this extrapolation and modelling is difficult 
to assess accurately.
A potentially more important source of error was the extent 
to which the workforce data used for the study included the 
informal workforce and ‘guest workers’ from other coun-
tries. The ILO denominator data are intended to include such 
workers, but this coverage is very likely to be moderate at best in 
countries such as India with a very large informal workforce and 
in countries with many child workers (who were excluded from 
the current analysis). In some countries and regions this may lead 
to considerable underestimation of the population at risk and 
therefore of the burden arising from occupational risk factors. 
Future iterations of the GBD study will attempt to improve 
coverage or otherwise adjust for lack of coverage.
Population at risk
The carcinogen analyses attempted to take into account the 
latency between exposure and occurrence of the related cancer 
when estimating the population at risk, and the fact that workers 
remain at risk of developing cancer long after they change jobs 
or leave the workforce, using estimates of workforce turn-
over and information on life expectancy for each region. The 
strengths and limitations of this approach, and of the approach 
to estimating exposure prevalence, are considered elsewhere.13 
Briefly, the principal uncertainties are that there is a general lack 
of information on the latency of specific cancers and uncertainty 
about variation in turnover worldwide.
Using industry and occupations as proxy measures for risk factors
A major source of uncertainty stems from the fact that industry 
and/or occupation were used as the sole or main basis for the 
risk factor exposure prevalence measures, lacking any data on 
actual exposure levels in different countries. For carcinogens, 
exposure prevalence data were available (from CAREX24) for 
individual carcinogens, but only for high- income countries and 
only on the basis of exposure prevalence, rather than on absolute 
exposure levels or cumulative exposures. For PMGF, prevalence 
data were based on limited published information modified by 
expert opinion. For noise, information was available for abso-
lute exposure levels within different industries, but only for one 
(high- income) region, and the analysis did not take into account 
the likely latency of noise- induced hearing loss.
Risk measures
The relative risk estimates came primarily from working cohorts 
of males in high- income countries and from a range of calendar 
time periods. The workers within the cohorts had a range of 
exposures in terms of length of exposure and intensity of expo-
sure. The length of follow- up varied. Therefore, there will have 
been some mismatch between the relative risk estimates used and 
the exposure circumstances to which they have been applied, 
particularly for LMI countries. Nevertheless, the measures used 
were considered the most appropriate available. A major gap 
in available relative risks was the lack of separate risk estimates 
for women and/or persons of different age for nearly all risk–
outcome pairs.
Exclusion of exposures and outcomes
There are many occupational exposures that are probably related 
to adverse health outcomes that were not included in the study 
reported here. These include International Agency for Research on 
Cancer Group 2A carcinogens (‘probably carcinogenic to humans’) 
associated with occupational exposures; infections arising from 
occupation; occupational exposures (apart from SHS) linked to 
ischaemic heart disease; pesticides; psychological and psychosocial 
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stresses; work organisation factors; and occupational exposures 
leading to musculoskeletal disorders (other than those affecting the 
lower back). These were excluded because there did not appear to 
be reliable data on one or both of the exposures or the associated 
risk measures; and/or because the level of evidence supporting a 
causal association was not considered sufficient. If a causal connec-
tion was accepted, many of these exposure–outcome pairs would 
be expected to result in a considerable number of deaths and/
or DALYs. Their exclusions might therefore be expected to have 
resulted in a considerable underestimation of the total burden 
arising from occupational risk factors. The most important exclu-
sions in terms of numbers of deaths are likely to be shift work, 
with breast cancer the associated outcome; occupational exposure 
to the ultraviolet component of sunlight, leading to skin cancer; 
exposures such as psychosocial factors resulting in ischaemic heart 
disease; and possibly occupational exposure to herbicides and 
insecticides in relation to non- Hodgkin’s lymphoma. In terms of 
DALYs, psychological and psychosocial stresses leading to adverse 
mental health outcomes, occupational exposures leading to muscu-
loskeletal disorders and heat- related disorders worsened by climate 
change would be expected to result in considerable burden.
Injury risk factors and injuries
Our estimates assumed the percentage (by age group and sex) of 
non- fatal injuries that were occupational equalled the percentage 
of fatal injuries that were occupational. Lack of data precluded 
a more refined estimation approach, but aggregate US data 
suggest that the assumption may severely underestimate non- 
fatal injuries (eg, in 1999, at ages 15–64, US occupational inju-
ries accounted for 5.7% of injury deaths and 19.9% of medically 
attended injuries25 26). Also, note that the estimates are likely 
to omit occupational injuries (and diseases) of sex workers and 
trafficked workers (who experience high rates of violent injury, 
sexually transmitted diseases and unintentional injury27 28) and 
most active- duty military injury deaths.
Overall effect of the limitations
The extent and direction of bias potentially arising from the 
major limitations is difficult to estimate with confidence for 
most of these limitations. Exclusion of some of the informal 
workforce, exclusion of some potentially important exposures 
and outcomes and use of fatal injury PAFs for non- fatal injury 
would all be expected lead to an underestimation of the associ-
ated burden. The approach used to estimate the population at 
risk and using industry and occupation as proxy measures for 
the prevalence of exposure to risk factors could result in bias in 
either direction. The use of CAREX for LMI countries might be 
expected to lead to an underestimation of exposure prevalence, 
and the use of relative risks from high- income countries for all 
countries might be expected to lead to an underestimation of risk 
in LMI countries, any error from these sources being expected 
to lead to an underestimation of the burden in LMI countries.
Recommendations for further work
This analysis has identified several areas where further research 
could improve the accuracy and usefulness of the burden esti-
mates. Several potentially important risk factor–outcome pairs 
were not included for various reasons, as mentioned earlier. 
Ongoing appraisal of the literature is being undertaken to 
address some of these, but better evidence regarding causal link 
will be required before decisions to include or exclude can be 
made confidently. There is also considerable scope for improve-
ment in the assessment of the prevalence of exposure to those 
risk factors that were included in this study. Maximising the 
inclusion of the unofficial workforce is important to overcome a 
potentially important source of underestimation of the exposed 
population. Data to support these approaches will be sought for 
upcoming GBD iterations.
COnCLuSIOn
Occupational exposures are an important cause of largely 
preventable disease and injury burden in all regions of the world. 
Changes in the burden over the last two decades, as highlighted 
through burden of disease studies, have varied considerably 
among risk factors and regions. The results provide guidance 
to assess priorities, as well as justification for prevention and 
control initiatives.
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